comparemela.com

Latest Breaking News On - Sequire biotechnology conference - Page 1 : comparemela.com

Aethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023

/PRNewswire/ Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease,.

Steven larosaSusan noonanJim frakesPrnewswire aethlon medical incCompany contactAethlon medical incDrug administrationSa noonan communicationsSequire biotechnology conferenceChief medical officerChief scientific officerAethlon medicalSequire biotechnologyVirtual eventsBreakthrough device

Wall Street Breakfast: The Week Ahead

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.

United statesCharlie chesbroughVictor dergunovEdmund inghamUniversity of californiaRegeneron pharmaceuticalsInternational paperWalgreens boots allianceFederal reserveChurch dwightVf corporationArcos dorados holdingsMinisterial monitoring committeeBill conerlyJoint ministerial monitoring committeeMeta platforms

BioCorRx to Present at Sequire Biotechnology Conference on February 2nd

27.01.2023 - Presentation on Thursday, February 2, 2023 at 2:00 PM ET ANAHEIM, CA, Jan. 27, 2023 (GLOBE NEWSWIRE) - via NewMediaWire - BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance use .

Lourdes felixBrady granierBiocorrx pharmaceuticalsBiocorrx incCrescendo communicationsUncraverx weight loss programSequire biotechnology conferenceChief executive officerChief financial officerSequire biotechnologyBiocorrx presentationVirtual eventsAddiction recoveryCognitive behavioral therapy

RenovoRx to Present at the Sequire Biotechnology Virtual Conference on February 2, 2023

RenovoRx, Inc. , a biopharmaceutical company focused on the localized treatment of solid tumors, today announced that Shaun Bagai, Chief Executive Officer, is scheduled to present virtually at the. | January 25, 2023

Shaun bagaiStrategic communicationsRenovorx incChief executive officerSequire biotechnology conferenceLocally advanced pancreatic cancerR pac clinicalRenovorx trans arterial micro perfusionOrphan drug designationNc stock exchangePress releaseT rnxt us75989r1077

vimarsana © 2020. All Rights Reserved.